Silver Book Fact

Annual AFib-related stroke Medicare costs

Stroke in Medicare patients with atrial fibrillation who were not treated with anticoagulants, cost Medicare $4.8 billion each year in direct costs. Those who had strokes despite prophylactic treatment cost an additional $3.1 billion.

Caro J. An Economic Model of Stroke in Atrial Fibrillation: The cost of suboptimal oral anticoagulation. Am J Managed Care. 2004; 10(14): S451-61. https://www.ajmc.com/view/dec04-1992ps451-s461

Reference

Title
An Economic Model of Stroke in Atrial Fibrillation: The cost of suboptimal oral anticoagulation
Publication
Am J Managed Care
Publication Date
2004
Authors
Caro J
Volume & Issue
Volume 10, Issue 14
Pages
S451-61
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Median age AFib patient
    The median age of people with atrial fibrillation is about 75 years.  
  • Heart failure rates among AFib patients
    A study of Medicare beneficiaries found that those with atrial fibrillation (AF) were significantly more likely to experience heart failure than their non-AF counterparts (36.7% versus 10.4%).  
  • Age as a risk factor of Afib
    At age 60, 1 in 25 Americans have AFib. At age 80+, this increases to nearly 1 in 10.  
  • Projected AFib prevalence
    Projected increases in the prevalence of Afib  
  • Heart failure in people with AFib
    AFib can also lead to heart failure. Within the first year of diagnosis, AFib patients have a 36.7% chance of experiencing heart failure– compared to 10.4% in those without AFib.